Kim Nayoung, Cao Weibiao, Song In Sung, Kim Chung Yong, Harnett Karen M, Cheng Ling, Walsh Michael P, Biancani Piero
Department of Medicine, Seoul National University, Bundang Hospital, Seoungnam, Gyeronggi-Do 463-707, Korea.
Am J Physiol Cell Physiol. 2004 Aug;287(2):C384-94. doi: 10.1152/ajpcell.00390.2003. Epub 2004 May 5.
Contraction of smooth muscle depends on the balance of myosin light chain kinase (MLCK) and myosin light chain phosphatase (MLCP) activities. Because MLCK activation depends on the activation of calmodulin, which requires a high Ca(2+) concentration, phosphatase inhibition has been invoked to explain contraction at low cytosolic Ca(2+) levels. The link between activation of the Ca(2+)-independent protein kinase Cepsilon (PKCepsilon) and MLC phosphorylation observed in the esophagus (ESO) (Sohn UD, Cao W, Tang DC, Stull JT, Haeberle JR, Wang CLA, Harnett KM, Behar J, and Biancani P. Am J Physiol Gastrointest Liver Physiol 281: G467-G478, 2001), however, has not been elucidated. We used phosphatase and kinase inhibitors and antibodies to signaling enzymes in combination with intact and saponin-permeabilized isolated smooth muscle cells from ESO and lower esophageal sphincter (LES) to examine PKCepsilon-dependent, Ca(2+)-independent signaling in ESO. The phosphatase inhibitors okadaic acid and microcystin-LR, as well as an antibody to the catalytic subunit of type 1 protein serine/threonine phosphatase, elicited similar contractions in ESO and LES. MLCK inhibitors (ML-7, ML-9, and SM-1) and antibodies to MLCK inhibited contraction induced by phosphatase inhibition in LES but not in ESO. The PKC inhibitor chelerythrine and antibodies to PKCepsilon, but not antibodies to PKCbetaII, inhibited contraction of ESO but not of LES. In ESO, okadaic acid triggered translocation of PKCepsilon from cytosolic to particulate fraction and increased activity of integrin-linked kinase (ILK). Antibodies to the mitogen-activated protein (MAP) kinases ERK1/ERK2 and to ILK, and the MAP kinase kinase (MEK) inhibitor PD-98059, inhibited okadaic acid-induced ILK activity and contraction of ESO. We conclude that phosphatase inhibition potentiates the effects of MLCK in LES but not in ESO. Contraction of ESO is mediated by activation of PKCepsilon, MEK, ERK1/2, and ILK.
平滑肌的收缩取决于肌球蛋白轻链激酶(MLCK)和肌球蛋白轻链磷酸酶(MLCP)活性的平衡。由于MLCK的激活依赖于钙调蛋白的激活,而这需要高浓度的Ca(2+),因此有人提出磷酸酶抑制作用可以解释在低细胞溶质Ca(2+)水平下的收缩现象。然而,在食管(ESO)中观察到的不依赖Ca(2+)的蛋白激酶Cepsilon(PKCepsilon)激活与MLC磷酸化之间的联系尚未阐明(Sohn UD、Cao W、Tang DC、Stull JT、Haeberle JR、Wang CLA、Harnett KM、Behar J和Biancani P. Am J Physiol Gastrointest Liver Physiol 281: G467 - G478, 2001)。我们使用磷酸酶和激酶抑制剂以及针对信号酶的抗体,结合来自ESO和食管下括约肌(LES)的完整和皂素通透的分离平滑肌细胞,来研究ESO中依赖PKCepsilon、不依赖Ca(2+)的信号传导。磷酸酶抑制剂冈田酸和微囊藻毒素 - LR,以及针对1型蛋白丝氨酸/苏氨酸磷酸酶催化亚基的抗体,在ESO和LES中引发了类似的收缩。MLCK抑制剂(ML - 7、ML - 9和SM - 1)以及针对MLCK的抗体抑制了LES中由磷酸酶抑制引起的收缩,但在ESO中没有。PKC抑制剂白屈菜红碱和针对PKCepsilon的抗体,但不是针对PKCbetaII的抗体,抑制了ESO的收缩,但没有抑制LES的收缩。在ESO中,冈田酸引发了PKCepsilon从细胞溶质向颗粒部分的转位,并增加了整合素连接激酶(ILK)的活性。针对丝裂原活化蛋白(MAP)激酶ERK1/ERK2和ILK的抗体,以及MAP激酶激酶(MEK)抑制剂PD - 98059,抑制了冈田酸诱导的ILK活性和ESO的收缩。我们得出结论,磷酸酶抑制增强了MLCK在LES中的作用,但在ESO中没有。ESO的收缩是由PKCepsilon、MEK、ERK1/2和ILK的激活介导的。